Literature DB >> 23477993

Gastro-oesophageal reflux disease.

Albert J Bredenoord1, John E Pandolfino, André J P M Smout.   

Abstract

Gastro-oesophageal reflux disease is one of the most common disorders of the gastrointestinal tract. Over past decades, considerable shifts in thinking about the disease have taken place. At a time when radiology was the only diagnostic test available, reflux disease was regarded as synonymous with hiatus hernia. After the advent of the flexible endoscope, reflux disease was, for a period, equated to oesophagitis. The introduction of oesophageal pH monitoring made us believe that reflux disease could be defined by an abnormally high proportion of time with oesophageal pH less than 4. Moreover, the successive arrival of histamine-2-receptor antagonists and proton-pump inhibitors changed our idea of treatment for the disease, with swings from and towards surgery, endoscopic techniques, and alternative pharmaceutical options.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23477993     DOI: 10.1016/S0140-6736(12)62171-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  28 in total

Review 1.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  Discontinuation of proton pump inhibitor therapy and the role of esophageal testing.

Authors:  John Pandolfino
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 3.  Barrett's esophagus in 2016: From pathophysiology to treatment.

Authors:  Irene Martinucci; Nicola de Bortoli; Salvatore Russo; Lorenzo Bertani; Manuele Furnari; Anna Mokrowiecka; Ewa Malecka-Panas; Vincenzo Savarino; Edoardo Savarino; Santino Marchi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

Review 4.  Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-11-12       Impact factor: 3.043

Review 5.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 6.  Eosinophilic Esophagitis Clinical Manifestations and Differential Diagnosis.

Authors:  Diana Muñoz-Mendoza; Adrián Chapa-Rodríguez; Sami L Bahna
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

Review 7.  An association between Helicobacter pylori and upper respiratory tract disease: fact or fiction?

Authors:  Shin Kariya; Mitsuhiro Okano; Kazunori Nishizaki
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

8.  Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction.

Authors:  Pingping Hu; Zhaofei Pang; Hongchang Shen; Guanghui Wang; Haifeng Sun; Jiajun Du
Journal:  Tumour Biol       Date:  2014-12-07

Review 9.  Revaluation of the efficacy of magnetic sphincter augmentation for treating gastroesophageal reflux disease.

Authors:  Hongke Zhang; Dinghui Dong; Zhengwen Liu; Shuixiang He; Liangshuo Hu; Yi Lv
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

10.  Serum diamine oxidase activity in patients with histamine intolerance.

Authors:  G Manzotti; D Breda; M Di Gioacchino; S E Burastero
Journal:  Int J Immunopathol Pharmacol       Date:  2015-11-16       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.